Aptamer Sciences Inc (KOSDAQ:291650)
South Korea
· Delayed Price · Currency is KRW 944.00
+7.00 (0.75%)
Last updated: Mar 25, 2025
Aptamer Sciences Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Operating Revenue | 1,083 | 243.19 | 358.25 | 269.28 | 228.51 | Upgrade
|
| Other Revenue | -0 | -0 | - | - | 0 | Upgrade
|
| Revenue | 1,083 | 243.19 | 358.25 | 269.28 | 228.51 | Upgrade
|
| Revenue Growth (YoY) | 345.26% | -32.12% | 33.04% | 17.84% | -43.94% | Upgrade
|
| Cost of Revenue | 310.81 | 52.1 | 71.67 | 112.86 | 71.06 | Upgrade
|
| Gross Profit | 772 | 191.08 | 286.58 | 156.41 | 157.44 | Upgrade
|
| Selling, General & Admin | 3,933 | 2,665 | 2,289 | 2,024 | 1,988 | Upgrade
|
| Research & Development | 3,144 | 9,359 | 6,025 | 1,763 | 1,770 | Upgrade
|
| Other Operating Expenses | 114.83 | 80.98 | - | - | - | Upgrade
|
| Operating Expenses | 7,824 | 12,398 | 8,606 | 4,224 | 4,080 | Upgrade
|
| Operating Income | -7,052 | -12,207 | -8,320 | -4,067 | -3,923 | Upgrade
|
| Interest Expense | -1,348 | -1,394 | -299.08 | -24.91 | -7.32 | Upgrade
|
| Interest & Investment Income | 620.9 | 1,082 | 564.16 | 247.17 | 80.07 | Upgrade
|
| Currency Exchange Gain (Loss) | -22.93 | 124.21 | -60.73 | -2.75 | -1.8 | Upgrade
|
| Other Non Operating Income (Expenses) | -1,470 | -1,207 | -185.76 | -0.41 | 0.61 | Upgrade
|
| EBT Excluding Unusual Items | -9,272 | -13,602 | -8,301 | -3,848 | -3,851 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -0.04 | 8.03 | Upgrade
|
| Gain (Loss) on Sale of Assets | 386.73 | - | - | 16.99 | - | Upgrade
|
| Other Unusual Items | 182.52 | - | - | - | - | Upgrade
|
| Pretax Income | -8,702 | -13,602 | -8,301 | -3,831 | -3,843 | Upgrade
|
| Income Tax Expense | - | - | -1,186 | - | - | Upgrade
|
| Net Income | -8,702 | -13,602 | -7,116 | -3,831 | -3,843 | Upgrade
|
| Net Income to Common | -8,702 | -13,602 | -7,116 | -3,831 | -3,843 | Upgrade
|
| Shares Outstanding (Basic) | 18 | 17 | 17 | 17 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 17 | 17 | 17 | 8 | Upgrade
|
| Shares Change (YoY) | 3.74% | 0.08% | 0.09% | 125.38% | 49.16% | Upgrade
|
| EPS (Basic) | -494.00 | -801.00 | -419.38 | -226.00 | -511.00 | Upgrade
|
| EPS (Diluted) | -494.00 | -801.00 | -419.38 | -226.00 | -511.00 | Upgrade
|
| Free Cash Flow | -6,977 | -11,534 | -6,085 | -10,555 | -3,758 | Upgrade
|
| Free Cash Flow Per Share | -396.07 | -679.22 | -358.63 | -622.68 | -499.67 | Upgrade
|
| Gross Margin | 71.30% | 78.57% | 79.99% | 58.09% | 68.90% | Upgrade
|
| Operating Margin | -651.23% | -5019.47% | -2322.35% | -1510.39% | -1716.79% | Upgrade
|
| Profit Margin | -803.68% | -5593.04% | -1986.19% | -1422.73% | -1681.97% | Upgrade
|
| Free Cash Flow Margin | -644.35% | -4742.72% | -1698.50% | -3919.93% | -1644.68% | Upgrade
|
| EBITDA | -6,172 | -11,654 | -7,821 | -3,628 | -3,575 | Upgrade
|
| D&A For EBITDA | 879.94 | 552.46 | 499.15 | 438.88 | 348.1 | Upgrade
|
| EBIT | -7,052 | -12,207 | -8,320 | -4,067 | -3,923 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.